Insider Transactions Reported by 18 Insiders of OptimizeRx Corp

Symbol
OPRX on Nasdaq
Industry
Services-Business Services, NEC
Location
260 Charles Street, Suite 302, Waltham, MA

Insiders trading volume in the past year

OptimizeRx Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Miriam Paramore President And Cso $5.57M Dec 2, 2021
William J. Febbo CEO, Director $4.61M +$100K +2.22% Feb 14, 2025
James Paul Lang Director $4.4M +$2.44M +125% Jun 11, 2025
Stephen L. Silvestro Chief Executive Officer $3.54M -$30.4K -0.85% Oct 3, 2025
Douglas P. Baker Chief Financial Officer $2.76M Oct 5, 2021
Edward Stelmakh Chief Finance & Strat Officer $2.42M Oct 3, 2025
Marion Odence-Ford Chief Legal & Admin Officer $1.7M Oct 3, 2025
Theresa Greco Chief Commercial Officer $1.52M Nov 1, 2025
Doug Besch Chief Product & Tech Officer $1.35M Oct 3, 2025
Andrew J. D'Silva Chief Business Officer $868K Oct 1, 2025
Gus D. Halas Director $866K Jun 5, 2024
Ellen O'Connor Vos Director $800K Jun 11, 2025
Patrick D. Spangler Director $773K -$194K -20.1% Aug 28, 2025
Gregory D. Wasson Director $630K Jun 11, 2025
Brendan W. Merrell Chief Operating Officer $510K Aug 21, 2025
Cathy Klema Director $238K Jun 11, 2025
Brian Clark McCarthy Chief Revenue Officer $102K Aug 2, 2024
Todd Inman Chief Technology Officer $30.5K Mar 1, 2023

Recent Insider Transactions by Companies or Individuals for OptimizeRx Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.